Ofatumumab monotherapy in relapsed/refractory mantle cell lymphoma--a phase II trial
- PMID: 24666179
- DOI: 10.1111/bjh.12769
Ofatumumab monotherapy in relapsed/refractory mantle cell lymphoma--a phase II trial
Keywords: CD20 antibody; mantle cell lymphoma; ofatumumab.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
